Publications by authors named "C Poncelet"
Objective: The aim of the TELESUR-GDM study was to demonstrate the non-inferiority of the onset of maternal, fœtal, and neonatal complications for patients with gestational diabetes mellitus (GDM) monitored by myDiabby HealthcareⓇ (app group) compared to patients with a classical glycaemic blood monitoring by diary (control group).
Materials And Methods: TELESUR-GDM was a retrospective, monocentric, and non-inferiority study including 349 patients in the app group and 295 patients in the control group. The primary outcome was a composite score based on maternal, foetal, and neonatal complications.
The objective of this study is to evaluate the association between quality and features related to internet users of the most viewed YouTube videos about COVID-19 and chloroquine, during the first wave of the pandemic. We conducted a cross-sectional observational study focusing on the most viewed YouTube videos on COVID-19 and chloroquine treatment, in French and English. The primary outcome was the association between video quality as assessed by DISCERN and modified JAMA scores, and video features related to internet users as assessed by number of viewership and likes.
View Article and Find Full Text PDFArticle Synopsis
- SARS-CoV-2 positive pregnant women have a varying risk of severe maternal adverse outcomes depending on the circulating variant, with higher risks during the Delta variant wave.
- A study of 2055 unvaccinated pregnant women from March 2020 to September 2022 showed 3.4% had severe outcomes in the pre-Delta period, increasing to 6.5% during Delta, and decreasing to 1.0% during Omicron.
- The study also highlighted that pregnancy complications were common across all periods, with stillbirth rates rising significantly during the Delta wave.
Article Synopsis
- The study investigates the effectiveness of a half-dose of antenatal betamethasone (11.4 mg) compared to the standard full dose (24 mg) in preventing respiratory distress syndrome in preterm infants while minimizing potential side effects.
- It is a randomized, double-blind, placebo-controlled trial conducted in 37 perinatal centers in France involving pregnant women at risk of preterm delivery who had already received the first injection of the medication.
- The primary outcome measured was the need for additional surfactant treatment within 48 hours of birth, with the researchers aiming to demonstrate that the half dose was non-inferior to the full dose based on specific statistical criteria.
Objectives: To provide clinical practice guidelines about fertility preservation (FP) for women with benign gynecologic disease (BGD) developed by a modified Delphi consensus process for oocyte vitrification in women with benign gynecologic disease.
Methods: A steering committee composed of 14 healthcare professionals and a patient representative with lived experience of endometriosis identified 42 potential practices related to FP for BGD. Then 114 key stakeholders including various healthcare professionals (n=108) and patient representatives (n=6) were asked to participate in a modified Delphi process via two online survey rounds from February to September 2020 and a final meeting.